LEAP THERAPEUTICS, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-13. The offering totals $77.2M, of which $77.2M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| James K Cavanaugh | Director | Cambridge, MA |
| Thomas K Dietz | Director | Cambridge, MA |
| William K Li | Director | Cambridge, MA |
| Joseph K Loscalzo | Director | Cambridge, MA |
| Patricia K Martin | Director | Cambridge, MA |
| Nissim K Mashiach | Director | Cambridge, MA |
| Christopher K Mirabelli | Director | Cambridge, MA |
| Douglas E Onsi | Director | Cambridge, MA |
| Christian K Richard | Director | Cambridge, MA |
| Richard K Schilsky | Director | Cambridge, MA |
| Christine Granfield | Executive Officer | Cambridge, MA |
| Augustine K Lawlor | Executive Officer | Cambridge, MA |
| Mark K O'Mahony | Executive Officer | Cambridge, MA |
| Douglas E Onsi | Executive Officer | Cambridge, MA |
| Cynthia K Sirard | Executive Officer | Cambridge, MA |
| JOSEPH LOSCALZO | Director | WALTHAM, MA |
| Christopher K Mirabelli | Executive Officer | Cambridge, MA |
| Augustine Lawlor | Executive Officer | South San Francisco, CA |
| William Li | Director | Mountain View, CA |
| Thomas Dietz | Director | Research Triangle Park, NC |
| John Littlechild | Director | Cambridge, MA |
| Nissim Mashiach | Director | Cambridge, MA |
| James Cavanaugh | Director | Cambridge, MA |
| Douglas Onsi | Executive Officer | Cambridge, MA |
| Christopher Mirabelli | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2017-11-29 | D | $18.0M | $18.0M |
| 2011-01-07 | D | $30.5M | $9.9M |